Mutolo D, Bongianni F, Cinelli E, Pantaleo T. Depression of cough reflex by microinjections of antitussive agents into caudal ventral respiratory group of the rabbit. J Appl Physiol 109: 1002-1010 , 2010 . First published July 22, 2010 doi:10.1152/japplphysiol.00406.2010.-We have previously shown that the caudal nucleus tractus solitarii is a site of action of some antitussive drugs and that the caudal ventral respiratory group (cVRG) region has a crucial role in determining both the expiratory and inspiratory components of the cough motor pattern. These findings led us to suggest that the cVRG region, and possibly other neural substrates involved in cough regulation, may be sites of action of antitussive drugs. To address this issue, we investigated changes in baseline respiratory activity and cough responses to tracheobronchial mechanical stimulation following microinjections (30 -50 nl) of some antitussive drugs into the cVRG of pentobarbital-anesthetized, spontaneously breathing rabbits. [D-Ala 2 ,N-Me-Phe 4 ,Gly 5 -ol]-enkephalin (DAMGO) and baclofen at the lower concentrations (0.5 mM and 0.1 mM, respectively) decreased cough number, peak abdominal activity, and peak tracheal pressure and increased cough-related total cycle duration (TT). At the higher concentrations (5 mM and 1 mM, respectively), both drugs abolished the cough reflex. DAMGO and baclofen also affected baseline respiratory activity. Both drugs reduced peak abdominal activity, while only DAMGO increased TT, owing to increases in expiratory time. The neurokinin-1 (NK1) receptor antagonist CP-99,994 (10 mM) decreased cough number, peak abdominal activity, and peak tracheal pressure, without affecting baseline respiration. The NK 2 receptor antagonist MEN 10376 (5 mM) had no effect. The results indicate that the cVRG is a site of action of some antitussive agents and support the hypothesis that several neural substrates involved in cough regulation may share this characteristic.
IN A PREVIOUS STUDY (42) we showed that the caudal nucleus tractus solitarii (cNTS) is a site of action of some centrally active antitussive drugs and a likely component of the complex neural system involved in cough regulation. The tested drugs were the selective -opioid receptor agonist [D-Ala 2 ,N-MePhe 4 ,Gly 5 -ol]-enkephalin (DAMGO), the GABA B receptor agonist baclofen, the neurokinin-1 (NK 1 ) receptor antagonist CP-99,994, and the NK 2 receptor antagonist MEN 10376. We also proposed (42) that several neural substrates involved in the regulation of cough (12, 16, 17, 31, 44, 46, 48, 56, 57) may be sites of action of antitussive drugs. In agreement with our previous suggestion and preliminary results (17, 42, 44) as well as the proposal by Bolser and colleagues (12, 49) , the responsive sites may comprise, in particular, the caudal part of the ventral respiratory column (2), i.e., the so-called caudal ventral respiratory group (cVRG), where bulbospinal expiratory neurons are concentrated (6, 30, 63) .
Several morphological and electrophysiological lines of evidence indicate that cVRG expiratory neurons are probably not involved in respiratory rhythmogenesis since very likely they do not have medullary axon collaterals (6, 14, 30, 41, 63) . However, microinjections of the broad-spectrum excitatory amino acid receptor agonist D,L-homocysteic acid (DLH) into the cVRG proved to cause transient inhibition of inspiratory activity associated with the activation of the expiratory motor output both in rats (18, 22) and cats (Refs. 13 and 49 also for further references). These findings have been interpreted as relevant to some physiological conditions, such as cough and other reflexes, that require the activation of expiratory motoneurons and the concomitant inhibition of inspiratory activity (35, 48, 53) . Evidence has also been provided that the excitatory drive to cVRG expiratory neurons is mediated by ionotropic glutamate receptors not only during eupneic breathing but also during cough (17, 43) . In addition, these studies led to the conclusion that neurons located in the cVRG have a crucial role in determining both the expiratory and the inspiratory components of the cough motor pattern but represent merely an expiratory output system for sneezing. We proposed that neurons of different types intermingled with the expiratory premotor neurons of the cVRG were most probably involved in the DLH-induced responses as well as in the effects caused by ionotropic glutamate receptor blockades on the cough reflex (13, 17, 43) . Interestingly, Poliacek et al. (49) showed that unilateral microinjections of DLH into the cVRG of anesthetized cats reduced cough number and associated abdominal thrusts, thus revealing the presence of a cough-suppressant neuronal network within this region. Furthermore, in agreement with previous suggestions (12, 17, 42, 44, 49) , codeine within the cVRG region proved to have an antitussive effect without a direct action on bulbospinal expiratory neurons (51) .
The present research was undertaken on pentobarbital-anesthetized, spontaneously breathing rabbits with the main purpose of ascertaining whether the cVRG could be a site of action of different centrally acting antitussive agents and a component of the neural system involved in cough regulation. We used the same antitussive agents already tested within the cNTS (42) . Thus a comparison of their effects within the two medullary regions could disclose some features of the central network controlling the cough reflex.
MATERIALS AND METHODS
Animal preparation. Experiments were carried out on 25 male New Zealand White rabbits (2.8 -3.4 kg) anesthetized with pentobarbital sodium (40 mg/kg iv, supplemented by 2-4 mg/kg every 30 min; Sigma-Aldrich, St. Louis, MO). Atropine (0.15 mg/kg im) was administered to reduce mucosal secretion in the airways. The adequacy of anesthesia was assessed by the absence of reflex withdrawal of the hindlimb in response to noxious pinching of the hindpaw. Additional criteria were the presence of a stable and regular pattern of phrenic bursts and the absence of fluctuations in arterial blood pressure or phrenic nerve activity, whether spontaneous or in response to somatic nociceptive stimulation. All animal care and experimental procedures were conducted in accordance with Italian legislation and the official regulations of the European Community Council on the use of laboratory animals (Directive 86/609/EEC). The study was approved by the Animal Care and Use Committee of the University of Florence.
Experimental procedures and details about the methods employed have been described previously (17, (42) (43) (44) . After cannulation of the trachea, polyethylene catheters were inserted into a femoral artery and vein for monitoring arterial blood pressure and for drug delivery, respectively. The animal was allowed to breathe through a nonrebreathing valve (model no. 112095-2384A, Hans Rudolph, Kansas City, MO) attached to the tracheal cannula. The C 3 or C5 phrenic root on either the right or left side was dissected free, cut distally, and prepared for recordings. The animal was placed in a prone position and fixed by a stereotaxic head holder and vertebral clamps; the head was ventroflexed for optimal exposure of the dorsal surface of the medulla by occipital craniotomy. Body temperature was maintained at 38.5-39°C by a heating blanket controlled by a rectal thermistor probe.
Recording procedures. Efferent phrenic nerve activity was recorded with bipolar platinum electrodes from the central stump of the cut and desheathed C 3 or C5 phrenic root. The electromyographic (EMG) activity of abdominal muscles was recorded by wire electrodes (Nichrome wires, insulated except for 1 mm at the tips, diameter 0.1 mm) inserted into the external or the internal oblique abdominal muscles. Phrenic and abdominal activities were amplified (ϫ2,000 -10,000), band pass filtered (80 -10,000 Hz), full-wave rectified, and "integrated" (low-pass RC filter, time constant 100 ms). Extracellular recordings from medullary neurons were made with tungsten microelectrodes (5-10 M⍀ impedance at 1 kHz). The most rostral extent of the area postrema on the midline was defined as the obex and used as a standard point of anatomic reference. Neuronal activity was recorded from expiratory neurons of the cVRG (1.6 -3.0 mm caudal to the obex, 2.0 -2.5 mm lateral to the midline, and 2.0 -2.6 mm below the dorsal medullary surface). Arterial blood pressure and intratracheal pressure were recorded by strain gauge manometers. End-tidal CO2 partial pressure was measured by an infrared CO2 analyzer (Datex, CD-102; Normocap, Helsinki, Finland). Integrated phrenic and abdominal activities as well as the signals of the other variables studied were recorded on an eightchannel rectilinearly writing chart recorder (model 8K20; NEC Sanei, Tokyo, Japan). Cardiorespiratory variables were also digitally acquired and analyzed with a personal computer equipped with an analog-to-digital interface (Digidata 1200, Axon Instruments, Union City, CA) and appropriate software (Axoscope, Axon Instruments).
Microinjection procedures. Microinjection procedures have been described fully in previous reports (17, (42) (43) (44) . Bilateral microinjections were performed into the cVRG at sites defined by prior extracellular recordings. The following antitussive drugs were used: DAMGO (0.5 and 5 mM), a -opioid receptor agonist; baclofen (0.1 and 1 mM), a GABAB receptor agonist; CP-99,994 (10 mM), a NK1 receptor antagonist; and MEN 10376 (5 mM), a NK2 receptor antagonist. All drugs were purchased from Sigma-Aldrich except CP-99,994 (gift from Pfizer, Groton, CT) and MEN 10376 (Tocris Cookson, Bristol, UK). A single preparation was employed to test the effects of each antitussive drug. Drug concentrations were in the same range as those previously used in in vivo preparations (4, 15, 20, 23, 36, 42, 54, 61) . All drugs were dissolved in 0.9% NaCl solution. The pH of the solutions was adjusted to 7.4 with either 0.1 N NaOH or 0.1 N HCl. As control treatment, injections of equal volumes of the vehicle solution were also made. Microinjections (30 -50 nl) were performed via a glass micropipette (tip diameter 10 -25 m) by applying pressure with an air-filled syringe connected to the micropipette by polyethylene tubing. The volume of the injectate was measured directly by monitoring the movement of the fluid meniscus in the pipette barrel with a dissecting microscope equipped with a fine reticule. The time taken to inject the solution ranged from 5 to 10 s. In each experiment, at first the rostral limit of the cVRG was determined by recording neuronal activity within the adjacent VRG where a mix of expiratory and inspiratory neurons is encountered (transitional area), approximately from 0.8 to 1.5 mm caudal to the obex. Successively, bilateral microinjections of the selected drug were made in the cVRG at three different sites, starting from ϳ0.5 mm caudal to the transitional area and continuing along the rostrocaudal extent of the VRG subregion at intervals of 0.5 mm. This procedure was followed to affect as much as possible the entire population of caudal expiratory neurons. Bilateral microinjections at the three selected sites were performed in succession with a single micropipette. The time taken to perform all the microinjections ranged from 6 to 8 min. The localization of injection sites is diagrammatically illustrated on a dorsal view of the medulla oblongata of the rabbit in Fig. 1 (see also Refs. 17, 43) .
Stimulation procedures. Cough was induced by means of a 0.5-mm-diameter nylon fiber with a smoothed tip inserted through a lateral port of the tracheal cannula until the tip was judged to be near the carina and main bronchi (17, (42) (43) (44) . To attain this condition we proceeded as follows. The nylon fiber was arranged in advance so that it just protruded from the caudal opening of the tracheal cannula, and its length was marked. The total length of the trachea (from the larynx to the carina) was ϳ6 cm as determined by means of postmortem measurements performed at the end of some previous experiments. During each experiment the trachea was cannulated for ϳ3 cm. The nylon fiber was inserted as far as the marked point and subsequently driven toward the carina. Back and forth movements of the fiber (ϳ3 cm) aimed at touching repeatedly (ϳ1 time every s) the carina or nearby airway walls were made over periods of 4 -5 s. The nylon fiber was calibrated as a von Frey monofilament with a precision balance. The force developed ranged from 8.8 to 11.8 mN (10.44 Ϯ 0.4 mN; n ϭ 10) and far exceeded the mechanical threshold described for all identified tracheal afferent nerve subtypes (52) . Mechanical stimulation was always executed by the same experimenter in order to ensure consistency of stimulation intensity and frequency between trials. In addition, this experimenter was unaware of the scheduled treatment. Much care was taken to perform tracheobronchial stimulation always at least 7-8 min after each supplemental dose of pentobarbital to avoid the possible immediate influences of the injected bolus on both breathing pattern and coughing. An interval of ϳ1 min was scheduled between cough stimulations. As a rule, three stimulation trials were performed in succession before drug administration. These stimulation trials were also accomplished ϳ5 min after the completion of all the microinjections and repeated at appropriate intervals (at least 4 -5 min) until complete recovery was observed or for a maximum of ϳ90 min.
Histology. At the end of each experiment, the animal was maintained on the stereotaxic head holder and the brain was perfused via a carotid artery with 0.9% NaCl solution and subsequently with 10% formalin solution. To obtain a brain stem block containing the pipette tracks, the brain was cut according to two transverse sections parallel to the frontal planes where the micropipettes had been placed. After at least a 48-h immersion in 10% formalin solution, the brain was placed in a hypertonic sucrose solution. Frozen 20-m coronal sections stained with cresyl violet were used for the histological control of pipette tracks and injection sites. In fact, as already illustrated in previous studies (17, 42, 44) , sections made at the appropriate levels show, as a rule, the entire tracks along which microinjections were performed and therefore the localization of micropipette tips and injection sites. The atlas of Meessen and Olszewski (40) was used for comparison.
Data collection and analysis. Respiratory variables were measured during baseline respiration and cough efforts. Inspiratory (TI) and expiratory (TE) times as well as the total duration of the respiratory cycle (TT) were measured on recordings of raw phrenic nerve activity. The respiratory frequency was subsequently calculated (breaths/min). Peak amplitudes (arbitrary units) of phrenic nerve activity and abdominal EMG activity were measured on integrated traces. Normalization of the amplitudes of phrenic and abdominal activities was performed by expressing them as a fraction (or percentage) of the highest achievable amplitude observed in each animal. The highest peak values were consistently observed during coughing. Therefore, all amplitudes are expressed in relative units (11, 42, 44) . Breathing pattern variables were measured for an average of five consecutive breaths before and after drug bilateral microinjections into the cVRG. In the same periods, end-tidal CO 2 partial pressure was measured breath by breath and averaged. Furthermore, systolic and diastolic blood pressures were measured at 2-s intervals; mean arterial pressure was calculated as the diastolic pressure plus one-third of the pulse pressure. Average values of cardiorespiratory variables observed in control conditions and at the time when the maximum response occurred were considered for statistical analyses (Sigma Stat, Jandel Scientific Software, San Rafael, CA). Owing to the small variations in respiratory and cardiovascular variables within each measurement period, average values were taken as single measurements for the purpose of analysis.
Cough responses to mechanical stimulation of the tracheobronchial tree were characterized by repeated coughs consisting of coordinated bursts of inspiratory activity and expiratory activity (16, 17, 42, 44, 46) . Each cough usually consisted of an augmented phrenic burst (preparatory inspiration) immediately followed by a burst of expiratory abdominal activity (17, 42, 44, 46) . A comparison between respiratory variables during control breathing and cough responses in the rabbit has been reported recently (44) . Cough-related variables were measured and averaged (3 stimulation trials) before and ϳ10 min after bilateral microinjections of antitussive drugs at the three selected sites, i.e., in the period when maximum effects on the cough reflex were present. These variables included cough-related TT, peak phrenic amplitude, peak abdominal activity, peak tracheal pressure, and cough number, i.e., the number of coughs induced by each stimulation. Average values of cough-related variables were taken as single measurements for subsequent statistical analysis. In some cases, the first obvious response following mechanical stimulation of the tracheobronchial tree was a small-amplitude expiratory effort without a preceding preparatory inspiration (16, 17, 44) . Accordingly, recordings of tracheal pressure show that this expiratory effort clearly occurs after the beginning of the expiratory phase of a control breath (see, e.g., Fig. 2 ). This pattern could fit more appropriately the definition of expiration reflex that is typically evoked by mechanical stimulation of the vocal folds (35) but can be also produced by mechanical stimulation of the tracheobronchial tree (62, 66) . In more detail, the cough reflex first draws air into the lungs to augment the force of the subsequent expulsive phase, thus promoting clearance of mucus and foreign particles from the respiratory tract. On the other hand, the expiration reflex is aimed at preventing aspiration of material into the tracheobronchial tree and lungs. Interestingly, the first reflex motor act in response to tracheobronchial stimulation is often an expiration reflex followed by a cough epoch (see present results and Refs. 16, 17, 35, 43, 44, 50, 62, 64, 66) . From the scrutiny of tracheal pressure recordings during coughing, we observed that in most cases the first expiratory effort following mechanical stimulation in the rabbit is immediately preceded by an inspiratory component of normal or even reduced amplitude. This expiratory effort was considered a real cough since it is preceded by an inspiration that is not aimed at preventing aspiration of foreign particles into the lungs. However, in our study an expiration reflex only occurred as the first motor event in a cough epoch, and its appearance was limited to a few (40) was used for comparison. NTS, nucleus tractus solitarii; NV, nucleus tractus spinalis nervi trigemini; NDV, nucleus dorsalis nervi vagi; NXII, nucleus nervi hypoglossi; NAC, nucleus ambiguus caudalis; NOI, nucleus olivaris inferior; P, tractus pyramidalis. C: photomicrograph of a coronal section of the medulla oblongata at approximately the same level as in B showing the location of a track along which a 5 mM DAMGO microinjection was made into the cVRG. Intense multiunit expiratory activity was recorded at this injection site.
occasions. Therefore, these expiratory responses were not considered for data analysis. In each preparation, microinjections of DAMGO and baclofen were performed at two concentrations. Comparisons between cardiorespiratory variables recorded during baseline breathing before and after administrations of DAMGO or baclofen were performed by means of one-way repeated-measures analysis of variance (ANOVA) followed by Student-Newman-Keuls tests. Changes in cardiorespiratory variables during baseline breathing as well as changes in cough-related variables observed in all the other experimental conditions were evaluated by Student's paired t-tests. All reported values are means Ϯ SE; P Ͻ 0.05 was taken as significant.
RESULTS

Drug-induced responses in cardiorespiratory variables during eupneic breathing.
Respiratory variables changed only after DAMGO or baclofen microinjections (Table 1) . DAMGO decreased respiratory frequency because of increases in TE and reduced peak abdominal activity or even abolished it at the higher concentrations (see also Fig. 2) . Baclofen decreased peak abdominal activity without any influence on the other respiratory variables (Table 1; respiratory activity developed progressively and reached their maximum within 8 -10 min, while recovery occurred within 45-60 min. Since it has been reported that changes in blood gas partial pressure could affect the intensity of the cough reflex (28), changes in end-tidal CO 2 partial pressure induced by DAMGO were evaluated. DAMGO administration at 0.5 and 5 mM caused similar increases in end-tidal CO 2 partial pressure from 28.50 Ϯ 0.63 to 32.95 Ϯ 0.69 (P Ͻ 0.001) and 33.52 Ϯ 0.71 (P Ͻ 0.001) mmHg, respectively. None of the tested antitussive drugs caused significant changes in mean arterial blood pressure (Table 1) .
Drug-induced changes in cough reflex. Changes in coughrelated variables 10 min after bilateral microinjections of antitussive drugs, i.e., when the maximum response occurred, are reported in Table 2 . Bilateral microinjections of 0.5 mM DAMGO (30 -50 nl; 15-25 pmol) at the selected sites of the cVRG were performed in six animals. These produced consistent reductions in cough number, peak abdominal activity, and peak tracheal pressure associated with increases in the coughrelated TT due to a rise in both TI and TE. Bilateral microinjections of 5 mM DAMGO (30 -50 nl; 150 -250 pmol) always abolished the cough responses. The suppression of the cough reflex occurred within 6 min and persisted for ϳ20 min. These effects are also illustrated by original recordings in Fig. 2 .
After bilateral microinjections (n ϭ 6) of 0.1 mM baclofen (30 -50 nl; 3-5 pmol) cough number, peak abdominal activity, and peak tracheal pressure decreased, while the cough-related TT augmented because of increases in both TI and TE. Baclofen Fig. 3 ). Cough suppression lasted for a maximum of 20 min.
Bilateral microinjections (n ϭ 5) of 10 mM CP-99,994 (30 -50 nl; 300 -500 pmol) induced decreases in cough number, peak abdominal activity, and tracheal pressure. In contrast, bilateral microinjections (n ϭ 5) of 5 mM MEN 10376 (30 -50 nl; 150 -250 pmol) did not produce any effect on the cough reflex ( Table 2) .
Cough reflex responses displayed a progressive recovery. With the lower concentrations of DAMGO and baclofen as well as with CP-99,994 a complete recovery was seen after 35-40 min. After drug-induced suppression of the cough reflex, a complete recovery was observed within 60 -80 min.
Controls. The localization of the injection sites was confirmed by histological control. Figure 1 illustrates the localization of injection sites on a dorsal view of the medulla oblongata as well as the distribution of injection sites within the cVRG along with an example of typical placement of the micropipette tip. For simplicity, only the distribution of sites where 5 mM DAMGO was injected has been reported. Bilateral control injections of equal volumes of the vehicle solution at the responsive sites (2 trials in 2 different animals before drug administration) were ineffective. In three additional rabbits, bilateral microinjections of each of the three effective drugs were performed at medullary locations sufficiently far (Ͼ0.8 mm) from the responsive sites (41, 43, 47) . These injections were performed [for comparisons see the atlas of Meessen and Olszewski (40) ] into the nucleus tractus spinalis nervi trigemini (n ϭ 2) as well as caudal to the cVRG (nucleus ambiguus caudalis, NAC in Fig. 1; n ϭ 3) or lateral to the cVRG into the adjacent reticular formation (n ϭ 2). These injections caused no appreciable changes in the pattern of breathing and cough responses: values of recorded variables were in the same range of control values reported in Tables 1 and 2 .
DISCUSSION
The major finding of this study is that some antitussive agents, such as DAMGO, baclofen, and CP-99,994, already shown to be effective at the level of the cNTS, are also active within the cVRG region. The results also support the hypothesis (42) that several neural substrates involved in cough regulation (12, 16, 17, 31, 44, 46, 48, 56, 57) may be sites of action of antitussive drugs. They are consistent with previous suggestions (12, 17, 42, 44, 49, 51) and extend previous findings on the action of antitussive drugs on the cVRG (42, 51) .
Microinjection techniques have been routinely used in our laboratory. A detailed description of these techniques along with a discussion of their reliability, the concentration of injected drugs, and the spread of the injectate has been already provided in our previous reports (14, 17, 41, 42, 44, 45) . Injection sites were selected by using stereotaxic coordinates and, especially, extracellular recordings from expiratory neurons of the cVRG (6, 14, 17, 32, 41, 63) . Their localization was confirmed by the histological control ( Fig. 1 ; see also Refs. 17, 43) . Our previous observations on the spread of the injectate Յ50 nl (14, 41, 45) are in agreement with theoretical calculations by Nicholson (47) suggesting that a volume of 50 nl should spread Ͻ385 m in any direction from the injection site. In fact, our histological examination of unstained coronal sections of the medulla oblongata showed that 0.1-0.2% pontamine sky blue dye added to the vehicle solution to mark the injection site produced approximately spherical dye spots of 0.65-to 0.8-mm diameter (14) . Since bilateral microinjections were made in the cVRG at three different sites (see MATERIALS AND METHODS) to affect as much as possible the entire rostrocaudal extent of the cVRG, this region was affected for a rostrocaudal extent of ϳ1.65-1.8 mm. Accordingly, bilateral microinjections of antitussive agents sufficiently far enough from the responsive sites did not affect the cough reflex. The specificity of drug-induced effects is also supported by the absence of changes in the cough reflex after control bilateral microinjections of the vehicle solution. In addition, similar drug concentrations have been shown previously to be selective in in vivo preparations (4, 15, 20, 23, 36, 42, 54, 61) , i.e., agonist and antagonist concentrations have been shown to be capable of activating or blocking the corresponding receptors in the absence of effects on other types of receptors or other nonspecific effects. Mechanical stimulation of the tracheobronchial tree is usually followed by a sequence of rhythmic expulsive cough efforts (11, 16, 17, 24, 35, 42, 44, 46) . In agreement with our previous findings (16, 17, 42, 44, 46) , repeated stimuli are required to trigger a cough epoch that appears with a variable latency and outlasts the stimulation period. These phenomena do not have a simple explanation. They are possibly related to the mechanisms required to overcome cough threshold, such as the time necessary for the activation of a sufficient number of receptors and the recruitment of higher-order sensory neurons. In addition, time is also required to reconfigure the respiratory network for rhythmic coughing (16, 48, 57) . Finally, we cannot exclude that uncertainties in marking the stimulation period may have contributed.
We observed some changes in baseline respiratory activity following DAMGO and baclofen microinjections. At variance with this, no effects on the eupneic pattern of breathing were observed in response to baclofen or morphine administered through the intravertebral arterial route (11) or in response to microinjections of codeine into the cVRG of the cat (51). We do not know the reasons for these discrepancies; however, differences in the animal species, in the experimental conditions and procedures, as well as in the specific drug employed may have played a role. It is interesting to note that small changes in the timing components of the breathing pattern, similar to those induced by DAMGO, were also seen after ionotropic glutamate receptor blockades within the cVRG region (17) . This suggests the existence in this region of a neural substrate directly or indirectly involved in determining respiratory timing. On the other hand, the notion that -opioid receptor and GABA B receptor agonists may have intense effects on both the intensity and timing of inspiratory activity is well established (6, 27, 37) . We cannot exclude that DAMGO and baclofen could have an action on cVRG expiratory neurons, but, in agreement with our previous proposal (13, 17) , we suggest that especially DAMGO most probably also affected other types of neurons either quiescent or with different respiratory or nonrespiratory discharge patterns (30, 32) . Both pre-and postsynaptic receptors may be involved (5, 6, 27, 34, 37, 54) . Neurons located in the cVRG project to other respiration-related brain stem regions, such as the rostral VRG, the parabrachialis medialis/Kölliker Fuse nuclei, and the NTS (25, 30, 59, 68) , and may influence the intensity and timing of respiratory bursts. The differences between the effects on baseline respiratory activity induced by DAMGO and baclofen microinjected respectively into the cNTS and the cVRG are clearly related to the site of injections and neuronal connectivity. In particular, the effects on peak abdominal activity observed in the present study could indicate a more direct involvement of pre-and postsynaptic mechanisms in affecting drive transmission to cVRG expiratory premotor neurons (17, 43) . It is worth noting that DAMGO-induced changes in the breathing pattern could have altered blood gases and, in particular, could have produced increases in blood CO 2 that have been reported to decrease the intensity of the cough reflex (28) . However, changes in end-tidal CO 2 partial pressure were relatively small (see RESULTS) and lower than those required to cause this effect (28) . For a discussion on the absence of effects on baseline respiratory activity in response to CP-99,994, see our previous report on the role of antitussive agents within the cNTS (42) .
Changes in cough-related variables induced by lower DAMGO or baclofen concentrations (Table 2 ) recall those observed during mechanically induced coughing after N-methyl-D-aspartate receptor blockade within the cNTS ( Table 2 in Ref. 44) or within the cVRG (17) except for the increases in TI. In addition, DAMGO and baclofen at the lower concentrations caused effects that were similar to those provoked by the same antitussive drugs microinjected into the cNTS (42) . Interestingly, peak phrenic nerve activity did not change. The present results are also in general agreement with those previously described by Bolser et al. (11) or those obtained by making use of codeine microinjections into the cVRG of the cat (51) . The effects observed on the inspiratory and expiratory motor output support the view of a different regulation of the inspiratory and expiratory components of the cough motor pattern (8) . However, in the present study as well as in our previous report on the central effects of antitussive drugs (42) , DAMGO and baclofen also increased cough-related TT because of increases in both cough-related TI and TE. Since peak phrenic amplitude was not affected, the increases in TI imply a reduced rate of rise of inspiratory activity (inspiratory drive) and, accordingly, an inspiratory depressant effect (63) . In the study by Bolser et al. (11) only high morphine doses were able to reduce diaphragm EMG amplitude and lengthen cough-related TT. The differences between the present results and those obtained with codeine microinjections into the cVRG region (51) are possibly due to differences in the animal species, experimental conditions, and characteristics of the employed drugs. For instance, codeine is a -opioid receptor agonist but may also exert its antitussive activity via several other mechanisms (51) . Furthermore, the rostrocaudal extent of the cVRG neuronal population affected by the injectate of antitussive drugs in the two studies was very different. Poliacek et al. (51) performed unilateral microinjections of 20 -30 nl, while we made bilateral microinjections of 30 -50 nl at three different sites (for the rostrocaudal extent of the area affected by our injections, see above).
Present and previous (42) results from our laboratory agree, at least in part, with the assumption by Bolser and colleagues (11, 12) on the presence of a cough-gating mechanism that does not participate in breathing pattern generation. However, at variance with their hypothesis, our results show that some antitussive agents may influence respiratory timing and inspiratory drive. Notably, the effects induced by antitussive drugs within the cNTS have already been widely discussed (42) , and the existence of a cough control system located outside the cough-generating network has been suggested. Previous studies (16, 46, 48, 56, 57) have provided evidence that the neuronal network implicated in the generation of the eupneic pattern of breathing is also involved in cough production. As mentioned above, we cannot rule out that DAMGO and baclofen may have directly affected cVRG expiratory premotor neurons. However, taking into account the recent finding by Poliacek et al. (51) that the expiratory bulbospinal neurons are relatively insensitive to codeine, we suggest that most probably antitussive drugs have exerted their action mainly on other types of cVRG neurons and influenced the timing of respiratory bursts through projections to other brain stem neural substrates involved in rhythm generation or pattern formation. As mentioned above, local effects may include both pre-and postsynaptic mechanisms. Remote effects due to disfacilitation or disinhibition phenomena are also possible (12) . Our interpretation is in keeping with recent findings suggesting the existence of a cough-suppressive neuronal network in the region of the cVRG distinct from expiratory bulbospinal neurons, and with the proposed model of cough-controlling neural pathways (49, 51) .
The results obtained with baclofen microinjections into the cVRG are consistent with the suggestion that GABAergic receptor mechanisms may be important in the regulation of the cough-suppressive mechanism (49) and with previous results showing that peripheral and central administration of baclofen inhibits cough in a dose-dependent manner (9) . It has also been shown that pretreatment with a specific GABA B receptor antagonist had no effect on the expression of cough but significantly reduced the cough-suppressive action of baclofen (7), thus indicating that GABA B receptors are not activated during coughing under control conditions. Rather, they are activated either under experimental conditions (baclofen administration) or under still-undefined natural conditions. Interestingly, it should be noted that the time courses of druginduced changes in the baseline respiratory activity and in the cough reflex are different, thus suggesting that the prolonged cough suppression is specific for this defensive reflex and does not represent a generalized depression of any respiratory motor output. These observations are in agreement with the abovementioned existence of a cough control system located outside the cough-producing respiratory network (11, 12, 42, 49) .
Microinjections of CP-99,994 within the cVRG caused suppressant effects on the cough reflex. This medullary region receives afferents from several regions including the NTS, the rostral ventrolateral medulla, the lateral tegmental field, the rostral ventral respiratory column, the medullary reticular formation, the retrotrapezoid nucleus, the dorsolateral pons, and the raphe nuclei (Refs. 6, 25, 30, 38, 59 ; see also Ref. 17 for further references). Most of these brain stem regions contain neurons involved in cough regulation (26, 31) . The depressant effects on the cough reflex obtained with microinjections of CP-99,994 into the cVRG are possibly related to substance P (SP) release from different sources, but most probably from the raphe nuclei, that are a source of SP also for the NTS (42) . In this context, it should also be mentioned that neurons of the periaqueductal gray project to cVRG neurons (29, 58, 60, 67) and are involved in the production of vocalization. However, these higher brain stem regions that have access to the cVRG may also be involved in other behaviors including coughing (60) .
Varied results have been obtained with CP-99,994 or different NK 1 receptor antagonists in anesthetized and unanesthetized animals of different species (1, 10, 11, 21, 33, 39, 42) . The reasons for the discrepancies are obscure, but they are possibly related to differences in animal species, experimental conditions, and type of preparation. Nevertheless, the present results are consistent with those described by Bolser et al. (10, 11) and Chapman et al. (21) . The absence of CP-99,994 effects on baseline respiratory activity suggests that SP is specifically involved in cough generation. As discussed for the cNTS (42), we do not know whether the role of SP within the cVRG may be relevant to central mechanisms involved in cough regulation, including central sensitization and plasticity phenomena induced by some pathophysiological conditions (19, 33, 42, 44, 65) . The results obtained with the NK 2 receptor antagonist MEN 10376 indicate that these receptors do not have any role in the control of both the eupneic pattern of breathing and the cough reflex (42) . These results are at variance with previous findings obtained in guinea pigs and cats with the NK 2 receptor antagonist SR48168 administered by either intracerebroventricular or intravertebral arterial route (10, 11) . The discrepancy may be due to the presence of other central sites of action of NK 2 receptor antagonists or to the presence of receptors with different binding properties in different animal species (55) .
In conclusion, the results provide evidence that the cVRG region is a site of action of the same antitussive drugs proven to be active at the level of the cNTS (42), thus extending previous suggestions and preliminary findings of our research group (42) as well as results reported in other studies (51) . They also show that drug-induced antitussive effects may vary according to the neuronal substrate involved. Furthermore, the results are consistent with the hypothesis that there is an endogenous cough-suppressive complex neuronal mechanism involving neurons located in the cVRG region (49, 51) . It remains to be investigated whether such a mechanism also affects other expulsive acts such as, for instance, the expiration reflex or sneezing. In agreement with our previous proposal (42) , the present findings strongly suggest that several different neuronal populations are responsive to antitussive drugs and that drug-induced effects on cough-related variables may depend on the route of administration, the actual concentration reached at the neuronal level, and the simultaneous action on all the existent cough-responsive sites following systemic administration. Further studies are needed to verify this hypothesis and ascertain whether other neural substrates involved in cough regulation (Refs. 12, 16, 17, 31, 46, 48, 56, 57 ; see also Ref. 44) are also sites of action of antitussive agents.
Cough is a very important airway defensive reflex (12, 35, 48, 53, 65 ) and a common symptom for which patients seek medical advice in many countries. However, antitussive drugs possess little clinically relevant efficacy, and their use is limited by important side effects (3) . The present results may improve our understanding of central neural mechanisms involved in the generation of the cough motor pattern and especially of those operating within the cVRG. Our results may also provide further insights into central phenomena of sensitization and plasticity relevant to the cough reflex and may guide the development of antitussive strategies. Our animal experimental model appears to be suitable for studies on the physiology and pharmacology of cough and may help to answer questions concerning airway defensive reflexes and to generalize results obtained in other animal species such as cats and guinea pigs.
